224 related articles for article (PubMed ID: 3486824)
21. Rapid histone deacetylation and transient HDAC association in the IL-2 promoter region of TSST-1-stimulated T cells.
Kametani Y; Wang L; Koduka K; Sato T; Katano I; Habu S
Immunol Lett; 2008 Aug; 119(1-2):97-102. PubMed ID: 18606456
[TBL] [Abstract][Full Text] [Related]
22. Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with antineutrophil cytoplasmic antibody-associated vasculitis and nephrosis.
Hirano T; Fukushima H; Sasaki Y; Yoshikawa N; Yoshida M; Oka K
Int Immunopharmacol; 2006 Jun; 6(6):924-34. PubMed ID: 16644478
[TBL] [Abstract][Full Text] [Related]
23. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
24. Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages.
Beezhold DH; Best GK; Bonventre PF; Thompson M
Rev Infect Dis; 1989; 11 Suppl 1():S289-93. PubMed ID: 2784586
[TBL] [Abstract][Full Text] [Related]
25. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
26. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
27. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
[TBL] [Abstract][Full Text] [Related]
28. Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1.
Kum WW; Hung RW; Cameron SB; Chow AW
J Infect Dis; 2002 Feb; 185(4):555-60. PubMed ID: 11865410
[TBL] [Abstract][Full Text] [Related]
29. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis.
Lester MR; Hofer MF; Gately M; Trumble A; Leung DY
J Immunol; 1995 Jun; 154(11):6174-81. PubMed ID: 7751657
[TBL] [Abstract][Full Text] [Related]
30. Toxic shock syndrome--the role of the toxin.
Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
[TBL] [Abstract][Full Text] [Related]
31. Synoviocyte proliferation in joints of SCID mice induced by toxic shock syndrome toxin-1 stimulated T cells from patient with rheumatoid arthritis.
Suzuki T; Nishimaki T; Kogure A; Okubo M; Akatsuka H; Kokubun M; Kasukawa R; Natsume T; Suzuki T
J Rheumatol; 1997 Jun; 24(6):1115-21. PubMed ID: 9195519
[TBL] [Abstract][Full Text] [Related]
32. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
33. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes.
Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A
Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082
[TBL] [Abstract][Full Text] [Related]
34. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen.
Takahashi N; Imanishi K; Nishida H; Uchiyama T
J Immunol; 1995 Dec; 155(11):5213-9. PubMed ID: 7594532
[TBL] [Abstract][Full Text] [Related]
35. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
37. Toxic shock syndrome toxin-1 accelerated collagen-induced arthritis in mice.
Kageyama Y; Koide Y; Nagata T; Uchijima M; Yoshida A; Arai T; Miura T; Miyamoto C; Nagano A
J Autoimmun; 2001 Mar; 16(2):125-31. PubMed ID: 11247638
[TBL] [Abstract][Full Text] [Related]
38. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
Kalyan S; Chow AW
J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
[TBL] [Abstract][Full Text] [Related]
39. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
[TBL] [Abstract][Full Text] [Related]
40. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
